title: Dutch guidelines for economic evaluation: 'from good to better' in theory but further away from pharmaceuticals in practice?
authors.affiliation: CESAV, Centre for Health Economics, IRCCS Institute for Pharmacological Research 'Mario Negri', 24020 Ranica (BG), Italy.
authors.forename: Livio
authors.initials: L
authors.lastname: Garattini
authors.affiliation: CESAV, Centre for Health Economics, IRCCS Institute for Pharmacological Research 'Mario Negri', 24020 Ranica (BG), Italy.
authors.forename: Anna
authors.initials: A
authors.lastname: Padula
mesh_terms: D003362:Cost-Benefit Analysis; D005069:Evaluation Studies as Topic; D017408:Guidelines as Topic; D006801:Humans; D009426:Netherlands; D004364:Pharmaceutical Preparations / Q000191:economics*
chemical_list: D004364:Pharmaceutical Preparations